The Swiss voice in the world since 1935

Swiss pharmaceutical firm lets dogs die cruel death 

dog in cage
Young beagles are being used for cruel animal experiments and left to die in a German laboratory working for a Swiss pharma firm, says the report. (Screenshot from SRF footage) SRF-SWI

Dogs are being left to die in agony in Germany after lab testing for the Swiss pharma company Inthera Bioscience, reports Swiss public television, SRF.

The dogs are young beagles, who are given high doses of substances for experiments on behalf of the Swiss biotech company, according to SRF. They are then left to die in agony with no care. 

The report carries disturbing photos by an employee of the animal protection organisation Soko Tierschutz. This employee got himself hired as a carer in the LPTExternal link animal testing laboratory in Hamburg, and documented for several months what was happening there, says the report.  

The pictures show tubes being inserted into a dog’s stomach and a test substance injected to find the dose at which severe side effects including death occur. The scenes show how the dogs suffer unnecessarily before their death, as they are left to die in agony. 

SRF says that the laboratory is violating international welfare regulations and that such proceedings would not be permitted in Switzerland. 

It quotes Friedrich Mülln of Soko Tierschutz as saying that such experiments are easier to carry out in Germany. “It is cheaper and the authorisation is simpler,” he says.  

Asked for a response, Swiss firm Inthera Bioscience wrote that the authorities have approved all tests but that the company would suspend further cooperation with the service provider, LPT, until it had a “clear picture of the situation”. 

LPT declined to answer specific questions but said such experiments were within the law and that its treatment of animals had never been questioned. An investigation into the service provider’s practices has been opened by the competent authorities following these findings, says SRF. 

More

 

Popular Stories

Most Discussed

News

Trump's policies darken the outlook for Swiss SMEs

More

Tariff gloom weighs on Swiss companies

This content was published on Small and medium-sized businesses (SMEs) in Switzerland are extremely pessimistic about ongoing geopolitical tensions and US President Donald Trump's tariff policy, according to a survey.

Read more: Tariff gloom weighs on Swiss companies
Renovation of Chillon Castle can continue

More

Renovation of Château de Chillon can go ahead

This content was published on The cantonal parliament of Vaud has approved a loan of CHF9.5 million ($11.5 million) for Château de Chillon, the most-visited monument in Switzerland.

Read more: Renovation of Château de Chillon can go ahead
Climate Alliance: an action plan for its 20th anniversary

More

Climate Alliance presents action plan on 20th anniversary

This content was published on The Swiss Climate Alliance has presented an action plan showing how Switzerland could make a success of the energy transition and achieve a net zero balance within ten years.

Read more: Climate Alliance presents action plan on 20th anniversary

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR